4 suspended. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Suspended 4 |
| Phase 1 | 3 | Suspended 3 |
Follow Schizophrenia: new trials by email Literature Review of Schizophrenia trials Research Report on Schizophrenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| D-serine AudRem: R33 Phase D-serine, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Suspended | New York State Psychiatric Institute | 60 | 2022-12-01 | 2026-11-02 |
| Accelerated TMS in Psychosis repetitive Transcranial Magnetic Stimulation (rTMS) - Schizophrenia, Schizoaffective Disorder | Phase 1 / Phase 2 | Suspended | Beth Israel Deaconess Medical Center | 20 | 2022-11-29 | 2026-04-22 |
| Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome Omega-3 polyunsaturated fatty acids, Xbox aerobic exercise, transcranial direct current stimulation,tDCS - Schizophrenia | Phase 2 | Suspended | Shanghai Mental Health Center | 120 | 2020-10-01 | 2023-04-18 |
| Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia APN1125, Placebo - Schizophrenia | Phase 1 / Phase 2 | Suspended | CoMentis | 30 | 2016-04-01 | 2016-07-13 |
Psychotic Disorders (2) · Schizotypal Personality Disorder (1)
Mental Disorders (4) · Schizophrenia Spectrum and Other Psychotic Disorders (4) · Personality Disorders (1)
Docosahexaenoic Acids (1) · Olanzapine (1) · Transcranial Direct Current Stimulation (1) · Transcranial Magnetic Stimulation (1)
Beth Israel Deaconess Medical Center (1) · CoMentis (1) · New York State Psychiatric Institute (1) · Shanghai Mental Health Center (1)
United States (3) · China (1)
David P Walling, PhD (1) · Roscoe O Brady, MD, PhD (1) · Yan Chen (1)
R33MH116093 (1)